Literature DB >> 23989691

[Primary immunodeficiency].

K R Engelhardt1, B Grimbacher, T Niehues.   

Abstract

Primary (inborn) immunodeficiency is caused by gene defects that impact both the innate and the adaptive immune system. Individuals with an immunedeficiency primarily come to medical attention with recurrent infections. Most diagnoses are first made in childhood and include cellular immunodeficiency, defects of phagocyte function and other primary immunodeficiencies. Antibody deficiencies, particularly common variable immunodeficiency (CVID) and complement defects may, however, not become manifested until adulthood. A pathological susceptibility to infection in adults is defined as more than three infections per year that require treatment with antibiotics and last longer than 4 weeks each. Clinical clues for immunodeficiency are pathological susceptibility to infections and immune dysregulation. The former is characterized by frequent and severe infections with often unusual pathogens, localization, course and/or intensity. Immune dysregulation comprises granulomas, autoimmune diseases, recurrent fever/chronic inflammation, tendency to eczema, lymphoproliferation and chronic enteritis. There are evidence-based guidelines and consensus documents for the diagnosis and treatment of primary immunodeficiencies. Therapeutic approaches depend on the nature of the immune defect and range from immunoglobulin substitution for antibody deficiencies to bone marrow transplantation for severe cellular immune defects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23989691     DOI: 10.1007/s00393-013-1161-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  17 in total

1.  Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.

Authors:  M Cicardi; K Bork; T Caballero; T Craig; H H Li; H Longhurst; A Reshef; B Zuraw
Journal:  Allergy       Date:  2011-11-30       Impact factor: 13.146

Review 2.  Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency.

Authors:  Kerstin Felgentreff; Ruy Perez-Becker; Carsten Speckmann; Klaus Schwarz; Krzysztof Kalwak; Gasper Markelj; Tadej Avcin; Waseem Qasim; E G Davies; Tim Niehues; Stephan Ehl
Journal:  Clin Immunol       Date:  2011-05-30       Impact factor: 3.969

Review 3.  Disease-causing mutations in genes of the complement system.

Authors:  Søren E Degn; Jens C Jensenius; Steffen Thiel
Journal:  Am J Hum Genet       Date:  2011-06-10       Impact factor: 11.025

4.  [Interdisciplinary AWMF guideline for the treatment of primary antibody deficiencies].

Authors:  J Krudewig; U Baumann; H Bernuth von; M Borte; U Burkhard-Meier; G Dueckers; E Foerster-Waldl; K Franke; P Habermehl; M Hönig; W Kern; K Kösters; K Kugel; T Lehrnbecher; J Liese; R Marks; G A Müller; R Müller; D Nadal; H-H Peter; D Pfeiffer-Kascha; M Schneider; H Sitter; P Späth; V Wahn; T Welte; T Niehues
Journal:  Klin Padiatr       Date:  2012-11-09       Impact factor: 1.349

Review 5.  Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update.

Authors:  E de Vries
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

6.  Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia.

Authors:  Donald C Vinh; Smita Y Patel; Gulbu Uzel; Victoria L Anderson; Alexandra F Freeman; Kenneth N Olivier; Christine Spalding; Stephen Hughes; Stefania Pittaluga; Mark Raffeld; Lynn R Sorbara; Houda Z Elloumi; Douglas B Kuhns; Maria L Turner; Edward W Cowen; Danielle Fink; Debra Long-Priel; Amy P Hsu; Li Ding; Michelle L Paulson; Adeline R Whitney; Elizabeth P Sampaio; David M Frucht; Frank R DeLeo; Steven M Holland
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

7.  Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency.

Authors:  Rachel Emma Dickinson; Helen Griffin; Venetia Bigley; Louise N Reynard; Rafiqul Hussain; Muzlifah Haniffa; Jeremy H Lakey; Thahira Rahman; Xiao-Nong Wang; Naomi McGovern; Sarah Pagan; Sharon Cookson; David McDonald; Ignatius Chua; Jonathan Wallis; Andrew Cant; Michael Wright; Bernard Keavney; Patrick F Chinnery; John Loughlin; Sophie Hambleton; Mauro Santibanez-Koref; Matthew Collin
Journal:  Blood       Date:  2011-07-15       Impact factor: 22.113

Review 8.  The complement system.

Authors:  J Vidya Sarma; Peter A Ward
Journal:  Cell Tissue Res       Date:  2010-09-14       Impact factor: 5.249

Review 9.  Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency.

Authors:  Mirjam van der Burg; Andy R Gennery
Journal:  Eur J Pediatr       Date:  2011-04-09       Impact factor: 3.183

10.  Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency.

Authors:  Waleed Al-Herz; Aziz Bousfiha; Jean-Laurent Casanova; Helen Chapel; Mary Ellen Conley; Charlotte Cunningham-Rundles; Amos Etzioni; Alain Fischer; Jose Luis Franco; Raif S Geha; Lennart Hammarström; Shigeaki Nonoyama; Luigi Daniele Notarangelo; Hans Dieter Ochs; Jennifer M Puck; Chaim M Roifman; Reinhard Seger; Mimi L K Tang
Journal:  Front Immunol       Date:  2011-11-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.